Barinthus Biotherapeutics plc reported earnings of per BRNS share on Nov 6, 2026, falling short of analysts' expectations by
| Report Date | Nov 6, 2026 |
|---|---|
| Forecasted EPS | -$ 0.27 |
| Last Year's EPS | -$ 0.41 |
| EPS YoY Change |
Out of the last 31 earnings reporting periods, Barinthus Biotherapeutics plc beat analysts’ expectations 17 times and fell short of expectations 7 time(s). Barinthus Biotherapeutics plc reported earnings per share of in the last report surpassing an estimated EPS of -$ 0.27 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 6, 2026 | -$ 0.27 | -$ 0.52 | - | |
| Aug 6, 2026 | -$ 0.28 | -$ 0.26 | -$ 0.49 | |
| Apr 30, 2026 | -$ 0.36 | -$ 0.14 | -$ 0.51 | |
| Mar 13, 2026 | -$ 0.40 | -$ 0.27 | -$ 0.21 | |
| Nov 7, 2025 | -$ 0.45 | -$ 0.36 | -$ 0.43 | |
| Aug 7, 2025 | -$ 0.29 | -$ 0.52 | -$ 0.40 | |
| May 7, 2025 | -$ 0.34 | -$ 0.49 | -$ 0.45 | |
| Mar 20, 2025 | -$ 0.50 | -$ 0.51 | -$ 0.37 | |
| Nov 6, 2024 | -$ 0.45 | -$ 0.21 | -$ 0.62 | |
| Aug 8, 2024 | -$ 0.42 | -$ 0.43 | -$ 0.48 | |
| May 13, 2024 | -$ 0.64 | -$ 0.40 | -$ 0.48 | |
| Mar 20, 2024 | -$ 0.55 | -$ 0.45 | -$ 0.56 | |
| Nov 9, 2023 | -$ 0.62 | -$ 0.37 | $ 0.22 | |
| Aug 10, 2023 | -$ 0.59 | -$ 0.62 | $ 0.216 | |
| May 12, 2023 | -$ 0.50 | -$ 0.48 | $ 0.4111 | |
| Mar 31, 2023 | -$ 0.50 | -$ 0.48 | $ 0.068 | |
| Dec 31, 2022 | -$ 0.43 | -$ 0.56 | $ 0.0677 | |
| Nov 10, 2022 | -$ 0.38 | $ 0.22 | $ 0.068 | |
| Sep 30, 2022 | -$ 0.38 | $ 0.216 | -$ 0.13 | |
| Jun 30, 2022 | -$ 0.32 | $ 0.4111 | -$ 0.13 |
Barinthus Biotherapeutics plc’s stock was trading at on Nov 5, 2026 a day before the last earnings report was released.
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Aug 6, 2026 | -$ 0.26 | $ 0.5701 | $ 0.599 | |
| Apr 30, 2026 | -$ 0.14 | $ 0.5999 | $ 0.6507 | |
| Mar 13, 2026 | -$ 0.27 | $ 0.60 | $ 0.68 | |
| Nov 7, 2025 | -$ 0.36 | $ 1.19 | $ 0.88 | |
| Aug 7, 2025 | -$ 0.52 | $ 1.31 | $ 1.34 | |
| May 7, 2025 | -$ 0.49 | $ 1.00 | $ 0.90 | |
| Mar 20, 2025 | -$ 0.51 | $ 0.99 | $ 0.99 | |
| Nov 6, 2024 | -$ 0.21 | $ 1.34 | $ 1.47 | |
| Aug 8, 2024 | -$ 0.43 | $ 1.39 | $ 1.35 | |
| May 13, 2024 | -$ 0.40 | $ 2.34 | $ 2.32 | |
| Mar 20, 2024 | -$ 0.45 | $ 2.41 | $ 2.41 | |
| Nov 9, 2023 | -$ 0.37 | $ 2.87 | $ 3.02 | |
| Aug 10, 2023 | -$ 0.62 | $ 2.20 | $ 2.08 | |
| May 12, 2023 | -$ 0.48 | $ 2.27 | $ 2.33 | |
| Mar 31, 2023 | -$ 0.48 | $ 2.30 | $ 2.25 | |
| Dec 31, 2022 | -$ 0.56 | $ 2.35 | $ 2.40 | |
| Nov 10, 2022 | $ 0.22 | $ 2.23 | $ 2.31 | |
| Sep 30, 2022 | $ 0.216 | $ 3.11 | $ 3.17 | |
| Jun 30, 2022 | $ 0.4111 | $ 5.11 | $ 4.61 | |
| May 11, 2022 | $ 0.068 | $ 4.17 | $ 3.09 |
Barinthus Biotherapeutics plc released its most recent earnings reports in November 2026, August 2026, April 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Barinthus Biotherapeutics plc beat analysts’ expectations during the last earnings period by
